Janus
- 22 Jan 2004 08:19
SueHelen
- 29 Jan 2004 09:29
- 18 of 145
In addition, good volume so far today. Trades over 15,000 shares are delayed by an hour. So the majority of earlier larger buys have appeared in the sell column.
SueHelen
- 29 Jan 2004 09:31
- 19 of 145
ckmtang
- 06 Feb 2004 07:46
- 20 of 145
is it still worth to buy it now? any furhter new will be announce?
SueHelen
- 06 Feb 2004 10:29
- 21 of 145
A distribution deal is due sometime soon. Price seems to have found a new trading range at the moment with limited downside.
ckmtang
- 06 Feb 2004 11:11
- 22 of 145
so when will be good to buy?
Janus
- 07 Feb 2004 17:29
- 23 of 145
Mediwatch mentioned in Shares Magazine this week.
Mediwatch chiefs scan for US profits
The likely prospect of a lucrative US distribution deal is good news for investors in AIM-listed Mediwatch (MDW).
Following publication of the interims, chief executive Philip Stimpson bought 125,000 shares and finance director Kevin Middis acquired 60,000 shares at 8.03p.
The company produces a bladder scanner which has recently received marketing approval from the FDA. This diagnostic kit can be used by a trained person, who need not be a doctor, to discover whether a patient needs specialist secondary care. It will be used in primary healthcare to screen for prostate illnesses.
Currently, the group has distribution agreements with CR Bard, one of the worlds largest suppliers of urological equipment, for distribution in parts of Europe. It is hoping to extend these arrangements to include Canada, Germany, Italy and Spain. It has signed similar distribution arrangements with a GE subsidiary to cover Japan and South-East Asia and is in the final stages of discussions about a distribution arrangement in the US an announcement is, we believe, imminent. Although currently most of the groups sales are in the UK, the company believes that in 2004/05, most will be generated overseas.
Last year, the company had to place 10 million shares at 2.5p and then seven million at 3.4p. Now that it has received FDA approval, the markets enthusiasm should continue to grow, especially when it is able to name its US partner. In the medium term, it is possible that its technology will attract a predator.
goldfinger
- 11 Feb 2004 00:40
- 24 of 145
added at the very end of the day, thats around 35% up in 2 days. Far more to come me thinks.
cheers GF.
Janus
- 11 Feb 2004 08:00
- 25 of 145
This was taken from another board, if true then very interesting.
Institute report - This company (MDW) is involved with a study that will inform future policy on screening for prostate cancer into a national programme. The study will take many years BUT results as they appear will be acted on earlier than the completed study. The bladder is the most likely area to develop cancer caused by radiation from X-rays ( The Lancet 2004) and ways to aviod this by new types of machinary is crucial. Any new ways to manage men with screen - detection of this disease will be supported by large sums of money.
kantona
- 11 Feb 2004 10:57
- 26 of 145
up by 7% today ..how far can this go ..holding tight
goldfinger
- 11 Feb 2004 11:49
- 27 of 145
Dont think we have seen anything until the distribution deal is announced.
cheers GF.
goldfinger
- 11 Feb 2004 21:06
- 28 of 145
Up again guys thats over 40% in three days. Still more to come though a lot more.
cheers GF.
goldfinger
- 11 Feb 2004 23:27
- 29 of 145
Fingers crossed hope to be hearing about this distribution deal soon.
cheers GF.
jfletendre
- 12 Feb 2004 00:59
- 31 of 145
Overgrowth - I read that post too and posted it on GF's thread - do you know enough about MDW and enough about calculating the sums in this to know if the above is accurate or just one person's very optimistic view?
goldfinger
- 12 Feb 2004 10:18
- 32 of 145
Very strong looking TA.

Positive Candidate (Medium term) - Feb 11, 2004
Has risen 555% since the bottom on 5 Jan 2004 at 2.25. An approximate horizontal trend is broken up. A continued strong development is indicated, and the stock now meets support on possible reactions down towards the trend lines. RSI is overbought. The stock can still rise further, and we should see a decreasing RSI before this is used as a negative signal. Positive volume balance, i.e. high volume in days of rising prices and low volume in days of falling prices, strengthens the stock in the short term. The stock has support at p 3.50. High risk with an average difference between the lowest and the highest price of the month of 46%.
cheers Gf.
ckmtang
- 12 Feb 2004 10:28
- 33 of 145
it seemed more seller rather than buyer now. can you confirmed.
goldfinger
- 12 Feb 2004 23:45
- 34 of 145
No problems I added again on the weakness this afternoon, and see these making me a very decent return.
cheers Gf.
goldfinger
- 13 Feb 2004 08:47
- 36 of 145
Agree with you overgrowth and have just topped up again, not many but money from some divis. See this as a great 2004 growth story.
cheers GF.
goldfinger
- 13 Feb 2004 09:29
- 37 of 145
Talk on another site that the distribution deal maybe out monday or tuesday.
Im hoping so.
cheers GF.